U.S. CDC COVID-19 Vaccine Committee Scheduled 2-Day Meeting

The draft agenda of the Advisory Committee on Immunization Practices (ACIP) digital meeting to review COVID-19 vaccines was published. This two-day ACIP meeting is scheduled for September 22, 2021, 10:00 a.m. – 4:30 p.m., and September 23, 2021, 12:00 p.m. – 3:30 p.m. ET.

The sessions and presentation for Wednesday are scheduled to discuss, but are not limited to, the following topics:

• Safety and immunogenicity for the 3rd dose of (Comirnaty) BNT162b2 Immunity and SARS-CoV-2.
• Vaccine effectiveness studies in the United States.
• Modeling the potential impact of booster doses in nursing home residents.
• Early safety monitoring for third doses of mRNA vaccines.
• VaST summary Work Group summary.
• Pregnancy: Safety monitoring in v-safe.
• Pregnancy: Safety monitoring in VSD.
• Updates on COVID-19 and pregnancy.

Any interested person who wishes to make an oral public comment during an ACIP meeting should submit a request with the U.S. CDC before the meeting according to the instructions in the Federal Register Notice. The ACIP Secretariat can be contacted at 1600 Clifton Road, N.E., Mailstop A27, Atlanta, GA 30329-4027 or [email protected]. 

The Advisory Committee on Immunization Practices webcast will be activated at this link.

Note: This post was updated on September 22, 2021.